The Innovation Award

Cell Signaling Technology

The CiteAb Innovation Award highlights an innovative product that has satisfied a gap in the market or solved a known issue within the respective field.

Many congratulations to Cell Signaling Technology, with their win in this category for their anti-CAR linker antibodies.

Yet again, we received many extremely strong nominations in this category and multiple products scored highly. The judges remarked on the quality of products entered and the difficulty in selecting one winner! After totalling each judge's scores, Cell Signaling Technology pulled ahead.

Their innovative new product has the potential to have far-reaching impact on cancer patients, helping in the development and optimisation of new treatments.

CAR-T therapy is an exciting new avenue in cancer treatment, where the patient's own immune cells are used against their tumour. However, to ensure the effectiveness of treatment, detection reagents must be developed to monitor CAR surface expression.

Cell Signaling Technology have introduced a product that can recognise many CAR-T cells: anti-CAR linker antibodies. This provides a solution to the lengthy and expensive process of developing specific antibodies to target individual CAR surface receptors, as these antibodies target the linker sequence between the heavy and light chain variable regions of the scFv meaning they can identify many receptors. These reagents can also be easily incorporated into flow panels, and are validated.

Dr Andrew Chalmers, CEO and founder of CiteAb said "We are thrilled to award Cell Signaling Technology with the Innovation Award for this product. Anti-CAR linker antibodies have the potential to create a really positive impact in cancer research. We were really excited to learn more about how the product has offered a solution to challenges in this field."

The judges:

Judge: Dr Andrew Chalmers
Dr Andrew Chalmers
CEO and founder of CiteAb
Judge: Momna Hejmadi
Momna Hejmadi
Faculty of Science Associate Dean
Judge: Robin Padilla
Robin Padilla
Director of Product Management at Springer Nature Experiments
Highly Commended

The Innovation Award highly commended:

Krishgen Biosystems, BSAb ELISAs

Other Categories

Explore additional categories featuring in the 2023 CiteAb Awards.

Award for Significant Individual Impact

Mathias Uhlén

The Innovation Award

Cell Signaling Technology

Highly Commended: Krishgen Biosystems

Charitable Initiative of the Year


Post Translational Modification Antibody Supplier of the Year

Cell Signaling Technology


Cell Line Supplier to Watch in 2023



Biochemical Supplier to Watch in 2023



Researchers' Choice

Hello Bio


Image of the Year

Josef Lavicky et al., from Masaryk University

Antibody Supplier of the Year


Cell Signaling Technology

Growth Factor Supplier of the Year


R&D Systems

ELISA Kit Supplier to Watch in 2023

Bioassay Technology Laboratory


Supplier Succeeding in Infectious Disease Research

Thermo Fisher Scientific

BD Biosciences